Neoadjuvant Chemo Did Not Improve Disease-Free Survival
-
By
-
Andrea Surnit
-
May 1, 2026
-
5 min
By
Andrea Surnit
May 1, 2026
Volume tracking and longitudinal imaging may enhance assessment of progression during active surveillance.
April 13, 2026
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026